These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
13. The pharmacokinetics of colistin in patients with cystic fibrosis. Reed MD; Stern RC; O'Riordan MA; Blumer JL J Clin Pharmacol; 2001 Jun; 41(6):645-54. PubMed ID: 11402633 [TBL] [Abstract][Full Text] [Related]
14. A pharmacokinetic/pharmacodynamic model developed for the effect of colistin on Pseudomonas aeruginosa in vitro with evaluation of population pharmacokinetic variability on simulated bacterial killing. Mohamed AF; Cars O; Friberg LE J Antimicrob Chemother; 2014 May; 69(5):1350-61. PubMed ID: 24474432 [TBL] [Abstract][Full Text] [Related]
15. Steady-state pharmacokinetics and BAL concentration of colistin in critically Ill patients after IV colistin methanesulfonate administration. Imberti R; Cusato M; Villani P; Carnevale L; Iotti GA; Langer M; Regazzi M Chest; 2010 Dec; 138(6):1333-9. PubMed ID: 20558557 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetics of Colistin Following a Single Dose of Intravenous Colistimethate Sodium in Critically Ill Neonates. Nakwan N; Usaha S; Chokephaibulkit K; Villani P; Regazzi M; Imberti R Pediatr Infect Dis J; 2016 Nov; 35(11):1211-1214. PubMed ID: 27276179 [TBL] [Abstract][Full Text] [Related]
17. In vitro activities of various antibiotics, alone and in combination with colistin methanesulfonate, against Pseudomonas aeruginosa strains isolated from cystic fibrosis patients. Güzel CB; Gerçeker AA Chemotherapy; 2008; 54(2):147-51. PubMed ID: 18322363 [TBL] [Abstract][Full Text] [Related]
18. A network meta-analysis of the efficacy of inhaled antibiotics for chronic Pseudomonas infections in cystic fibrosis. Littlewood KJ; Higashi K; Jansen JP; Capkun-Niggli G; Balp MM; Doering G; Tiddens HA; Angyalosi G J Cyst Fibros; 2012 Sep; 11(5):419-26. PubMed ID: 22717535 [TBL] [Abstract][Full Text] [Related]